surrogate 发表于 2025-3-26 21:05:18

http://reply.papertrans.cn/59/5869/586868/586868_31.png

Cpr951 发表于 2025-3-27 01:30:12

http://reply.papertrans.cn/59/5869/586868/586868_32.png

人类的发源 发表于 2025-3-27 06:21:43

http://reply.papertrans.cn/59/5869/586868/586868_33.png

规章 发表于 2025-3-27 11:04:16

The use of metabolic measurements in angiographic regression trialstherapeutic interventions and to generate new hypotheses concerning the determinants of coronary atherosclerosis. All analytical and biological sources of variation should be minimized, with consistent use of quality control material and, ideally, a reference laboratory. Potential confounders in stu

未完成 发表于 2025-3-27 16:57:23

Quality control in quantitative coronary arteriographyand later by quantitative coronary arteriography (QCA), sometimes supported by visual interpretation. The higher accuracy and precision of the computer-aided approach, however, can only be achieved under highly standardized circumstances. An overview is given on the necessary precautions to be taken

tendinitis 发表于 2025-3-27 21:14:47

http://reply.papertrans.cn/59/5869/586868/586868_36.png

贞洁 发表于 2025-3-28 00:08:04

http://reply.papertrans.cn/59/5869/586868/586868_37.png

Instantaneous 发表于 2025-3-28 05:09:25

http://reply.papertrans.cn/59/5869/586868/586868_38.png

glucagon 发表于 2025-3-28 06:34:31

http://reply.papertrans.cn/59/5869/586868/586868_39.png

IOTA 发表于 2025-3-28 10:58:11

http://reply.papertrans.cn/59/5869/586868/586868_40.png
页: 1 2 3 [4] 5 6
查看完整版本: Titlebook: Lipid-Lowering Therapy and Progression of Coronary Atherosclerosis; Albert V. G. Bruschke,Johan H. C. Reiber,Hein J. J Book 1996 Kluwer Ac